Advacine Biotechnology Company is a leading innovator in the field of vaccines and biopharmaceuticals, leveraging advanced internal technology platforms to develop high-value preventive and therapeutic vaccines, as well as innovative drugs. The company utilizes a robust antigen technology platform, an adjuvant technology platform, and a drug delivery technology platform to create and manufacture its products. Their primary research and development focus includes areas such as infectious diseases, cancer, and microneedle delivery systems, aiming to address both preventive and therapeutic needs in these critical fields.

The company's commitment to innovation is reflected in its strategic approach to enhancing research and development capabilities, expanding production capacity, and establishing a comprehensive commercialization strategy and sales network. Advaccine is actively seeking opportunities for licensing, investment, and acquisitions to further bolster its pipeline of vaccines and drugs, ensuring that it remains at the forefront of biopharmaceutical advancements.

China

The company develops vaccines toinduceimmunotolerance or stimulate T cells, for certain diseases. Beijing Advaccine is also collaborating with Inovio Pharmaceuticals on a novel vaccine to prevent COVID-19.

Advaccine Biotechnology Company

Company Details